| Views | |
|---|---|
| Correction of morphofunctional disorders with asialoerythropoietin and selective inhibitor of arginase II KUD975 in cases of ischemic kidney damage in the experiment | 47 |
| August 2025 | September 2025 | October 2025 | November 2025 | December 2025 | January 2026 | |
|---|---|---|---|---|---|---|
| Correction of morphofunctional disorders with asialoerythropoietin and selective inhibitor of arginase II KUD975 in cases of ischemic kidney damage in the experiment | 1 | 4 | 9 | 4 | 1 | 6 |
| Views | |
|---|---|
| Elagin_Correction.pdf | 13 |
| Views | |
|---|---|
| United States | 14 |
| Canada | 3 |
| Brazil | 2 |
| Ecuador | 2 |
| Netherlands | 2 |
| Russia | 2 |
| Vietnam | 2 |
| Australia | 1 |
| China | 1 |
| Peru | 1 |
| Views | |
|---|---|
| San Jose | 4 |
| Ottawa | 3 |
| Quito | 2 |
| San Francisco | 2 |
| Amsterdam | 1 |
| Asheville | 1 |
| Beijing | 1 |
| Caulfield | 1 |
| Chicago | 1 |
| Den Haag | 1 |